Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| The Global Radiation Oncology Devices Market to Upsurge at a CAGR of ~8% by 2027 | DelveInsight | ||||||||||||||||||||||||||||||||||||
| By: PR Newswire Association LLC. - 30 Jan 2023 | Back to overview list |
|||||||||||||||||||||||||||||||||||
|
Rising cancer cases, rapid technological development activities, strong R&D initiatives from key players, rising adoption of radiotherapy procedures in cancer treatment, and increasing demand for minimally invasive procedures are all contributing to the radiation oncology devices market growth during the forecast period. LAS VEGAS, Jan. 30, 2023 /PRNewswire/ -- DelveInsight's Radiation Oncology Devices Market Insights report provides the current and forecast market analysis, individual leading radiation oncology devices companies' market shares, challenges, radiation oncology devices market drivers, barriers, and trends, and key radiation oncology devices companies in the market.  Key Takeaways from the Radiation Oncology Devices Market Report
To read more about the latest highlights related to the radiation oncology devices market, get a snapshot of the key highlights entailed in the Global Radiation Oncology Devices Market Report Radiation Oncology Devices Overview Radiation therapy (RT) uses high-energy X-rays or other particles to destroy tumor cells. It is used to slow or stop tumor growth and is usually given after surgery, and may be combined with chemotherapy. The most common type of radiation treatment is external-beam radiation therapy, which delivers radiation from a machine outside the body. Internal radiation therapy, also known as brachytherapy, is the delivery of radiation therapy through implants. Radiation Oncology Devices Market Insights Among all regions, North America is expected to account for the largest share of the global radiation oncology devices market. Rising cancer prevalence, supportive government policies, increased emphasis on promoting oncology research, and a favorable environment for product development and launch will drive the region's radiation oncology devices market growth. Furthermore, the increased emphasis on product development activities and device manufacturers' eagerness to enter local markets contribute to the expansion of regional radiation oncology device markets. For example, Alpha Tau's alpha-radiation cancer therapy breakthrough device designation was granted by the US Food and Drug Administration (FDA) in October 2021 to treat patients with recurrent glioblastoma multiforme (GBM). These types of product launches in local markets drive demand for radiation oncology devices in the market. The North American radiation oncology devices market is expected to grow during the forecast period due to the interaction of various factors, such as the presence of a large patient population, encouraging reimbursement policies, and new product launches in the region. To know more about why North America is leading the market growth in the radiation oncology devices market, get a snapshot of the Radiation Oncology Devices Market Outlook Radiation Oncology Devices Market Dynamics The radiation oncology devices market is experiencing increased product demand for a variety of reasons; one of which is the rising prevalence of various cancers. Radiation oncology devices are in high demand in the field of medical imaging these days. Radiation oncology devices are an effective imaging technique that aids physicians in diagnosing cancers in the brain, prostate, lung, and other organs. However, the high costs of procedures and the side effects associated with radiation may be limiting factors in the growth of the radiation oncology devices market. Furthermore, outpatient visits were canceled due to the pandemic, as were non-emergency hospitals and procedures. As a result, the number of routine clinical examinations and related procedures for visits was reduced. However, the development of the COVID-19 vaccine has started the process of economic recovery, with the easing of lockdown restrictions and the return of normalcy in the economic landscape, which has started the process of resumption of regular healthcare services such as outpatient visits, thereby increasing demand in the radiation oncology devices market. Get a sneak peek at the radiation oncology devices market dynamics @ Radiation Oncology Devices Market Dynamics Analysis
Radiation Oncology Devices Market Assessment
Which MedTech key players in the radiation oncology devices market are set to emerge as the trendsetter explore @ Radiation Oncology Devices Companies Table of Contents
Interested in knowing the radiation oncology devices market by 2027? Click to get a snapshot of the Radiation Oncology Devices Market Trends Related Reports Cancer Therapy Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cancer therapy companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, among others. Intratumoral Cancer Therapies Market Intratumoral Cancer Therapies Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, along with emerging drugs and key intratumoral cancer therapies companies, including Daiichi Sankyo, Amgen, Idera Pharmaceuticals, Philogen, among others. Oncology Drugs Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key oncology drugs companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, among others. Intratumoral Cancer Therapies Market Intratumoral Cancer Therapies Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key intratumoral cancer therapies companies, including Daiichi Sankyo, Amgen, Idera Pharmaceuticals, among others. Liquid Biopsy in Cancer Diagnostics Market Liquid Biopsy in Cancer Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key liquid biopsy in cancer diagnostics companies, including Myriad Genetics Inc, Exact Sciences Corporation, Biocartis, Sysmex Corporation, among others. Other Trending Reports Tay-sachs Disease Or Gm2 Gangliosidosis Market | Onycholysis Market | Diagnostic Imaging Equipment Market | Chemotherapy-induced Peripheral Neuropathy Market | Global Electrophysiology Devices Market | Anaphylaxis Market | Atherectomy Devices Market | Helicobacter Pylori Infections Market | Ophthalmic Imaging Equipment Market | Androgenetic Alopecia Market | Allergic Rhinitis Market | Chronic Inflammatory Demyelinating Polyneuropathy Market | Chronic Inflammtory Demyelinating Polyneuropathy Market | Colorectal Cancer Crc Market | Opioid Induced Constipation Market | Vertigo Market | Bone Anchored Hearing Systems Market | Wound Closure Devices Market | Hip Replacement Devices Market | Hemodynamic Monitoring Systems Market | Egfr Non-small Cell Lung Cancer Market | Helicobacter Pylori Infection Market | Hyperkalemia Market | Polycythemia Market Neurostimulation Devices Market | Carpal Tunnel Syndrome Market | Ventilator Market | Cerebral Aneurysm Market | Alpha Antitrypsin Market | Binge Eating Disorder Market | Bunion Market | Concussions Market Size | Exocrine Pancreatic Insufficiency Market | Healthcare Due Diligence Services | Minimal Residual Disease Market | Hypertrophic Scar Market | Lung Fibrosis Market | Anterior Uveitis Market | 22q11.2 deletion syndrome Market | X-Linked Retinitis Pigmentosa (XLRP) Market | Acute Radiation Syndrome Market | Alpha-1 Protease Inhibitor Deficiency Market | Androgenetic Alopecia Market | Hyperlipidemia Market | Cardiotoxicity Market | Hypertrophic Cardiomyopathy Market | Fatty Acid Oxidation Disorders (FAODs) Market | Androgen Insensitivity Syndrome Market | Emphysema Market | Canaloplasty Market | Dravet Syndrome Market | Celiac Disease Market | Chlamydia Infections Market | Syphilis Market | Renal Tubular Acidosis Market | Palmoplantar Pustulosis (PPP) Market | Aplastic Anemia Market | Bacterial Pneumonia Market | B cell Chronic Lymphocytic Leukemia Market | B cell Lymphomas Market | Behcets Disease Market Neoantigen-based Personalized Cancer therapeutic Vaccines Competitive Landscape and Market Forecast—by 2035 | Glioblastoma Market Related Healthcare Blogs Upcoming Oncological Drugs in 2022 Metastatic Castration-Sensitive Prostate Cancer Treatment Market Related Cases Studies Related Healthcare Services Healthcare Competitive Intelligence Services Healthcare Asset Prioritization Services About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve. Connect with us on LinkedIn|Facebook|Twitter Additionally, get in touch with our business executive to explore @Healthcare Due Diligence Services Contact Us Shruti Thakur Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
SOURCE DelveInsight Business Research, LLP 
|
||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||
 | Back to overview list | |||||||||||||||||||||||||||||||||||
View original content: